- Home
- ACNB vs VNDA Comparison
ACNB vs VNDA Comparison
Compare ACNB & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNB
- VNDA
- Stock Information
- Founded
- ACNB 1857
- VNDA 2002
- Country
- ACNB United States
- VNDA United States
- Employees
- ACNB N/A
- VNDA N/A
- Industry
- ACNB Major Banks
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- ACNB Finance
- VNDA Health Care
- Exchange
- ACNB Nasdaq
- VNDA Nasdaq
- Market Cap
- ACNB 372.5M
- VNDA 270.2M
- IPO Year
- ACNB N/A
- VNDA 2006
- Fundamental
- Price
- ACNB $42.24
- VNDA $4.73
- Analyst Decision
- ACNB Buy
- VNDA Buy
- Analyst Count
- ACNB 2
- VNDA 1
- Target Price
- ACNB $37.00
- VNDA $13.00
- AVG Volume (30 Days)
- ACNB 15.1K
- VNDA 671.2K
- Earning Date
- ACNB 10-29-2024
- VNDA 11-06-2024
- Dividend Yield
- ACNB 2.99%
- VNDA N/A
- EPS Growth
- ACNB N/A
- VNDA N/A
- EPS
- ACNB 3.66
- VNDA N/A
- Revenue
- ACNB $106,710,000.00
- VNDA $182,022,000.00
- Revenue This Year
- ACNB N/A
- VNDA $6.70
- Revenue Next Year
- ACNB $21.19
- VNDA $51.03
- P/E Ratio
- ACNB $11.68
- VNDA N/A
- Revenue Growth
- ACNB N/A
- VNDA N/A
- 52 Week Low
- ACNB $30.24
- VNDA $3.30
- 52 Week High
- ACNB $48.55
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- ACNB 49.12
- VNDA 48.57
- Support Level
- ACNB $41.56
- VNDA $4.68
- Resistance Level
- ACNB $44.45
- VNDA $4.98
- Average True Range (ATR)
- ACNB 1.03
- VNDA 0.18
- MACD
- ACNB -0.00
- VNDA 0.05
- Stochastic Oscillator
- ACNB 40.05
- VNDA 40.00
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Bank which generates the majority of the revenue provides banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.